Men: associations between uric acid level (µM) and the onset of impaired fasting glucose* for high plasma glucose levels.

The aHR is expressed per µM increment in uric acid value.Model 1 was adjusted for all variable that were previously reported to be associated with metabolic disease or risk factors for the onset of glucose intolerance: age (years), BMI (kg/m2), systolic blood pressure (mmHg), triacylglycerols (mM), high-density lipoprotein cholesterol (mM), creatinine (µM), fatty liver (%), family history of diabetes (%), alcohol drinking status (%), and current smoking status (%).Model 2 was adjusted for all factors that were significant in univariate analyses: age, BMI, triacylglycerols, fatty liver, and current smoking status.Model 3 was adjusted for all factors that were significant in univariate analyses, excluding fatty liver: age, BMI, triacylglycerols, and current smoking status.*Onset of impaired fasting glucose was defined as a fasting plasma glucose level ≥6.11 mM.aHR, adjusted hazard ratio; CI, confidence interval; BMI, body mass index.Men: associations between uric acid level (µM) and the onset of impaired fasting glucose* for high plasma glucose levels.